Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Testicular Cancers Ashray Gunjur Intern, Royal Melbourne Hospital Did you know? • That the words testify, testimonial and testament are derived from... Anatomy http://www.aboutcancer.com/testicle_anatomy1.jpg Differentials HISTORY? * Pain?? * Time course of symptoms? PHYSICAL EXAM? * pain? * reducibility? * Lie of teste? Differentials Toronto Notes 2010 Differentials • 1) Hydrocele Differentials • 2) Epidydymal cyst/Spermatocele Differential • 3) Varicocele Typical case • Young man with painless growth of unilateral teste • On examniation, firm nontender, nontransilluminating mass in one of the testes Epidemiology • Relatively rare- 1-2% of men, but.. • Most common malignancy in age 20-40 • Three peak model: infancy, 30-34 years, >60 years Risk factors • Cryptorchidism- 4-8x risk of germ cell tumour – Risk still increased after orchiopexy in pt <6yrs old2.23x* – Risk still increased in contralateral testis- 5-20% of malignancy in normal descended testis! • Prior testicular cancer- 500x – Approx 1-2% of testicular cancer patients will develop a second primary contralaterally... *Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. May 3 2007;356(18):1835-41 Risk factors • Genetics – E.g. Klinefelter syndrom (47XXY)- germ cell tumours • Diethylstilbestrol (DES) exposure in utero – E.g. ‘Agent Orange’, Industrial occupation Diagnosis • Best first test hypoechoic lesion Diagnosis • Gold standard? - inguinal orchidectomy!! Histologic types Germ cell tumors (>95%): Seminoma (40%) versus Non seminomatous germ cell tumors (NSGCT) (40%) vs. mixed (15%) Non-germ cell tumors (rare, <5%) Leydig cell tumors (precocious puberty) Sertoli cell tumors Mixed sex chord-stromal tumors Germ cell tumours • Seminoma (40%) – Generally favourable prognosis, tend to be in older men – Rarely make B-HCG (15%), no aFP (0%) • Non-seminoma (40%) – Choriocarcinoma (elevated b-HCG (50%), haematogenous spread) – Embryonal cell – Teratoma (mature and immature) – Yolk sac (elevated AFP) Tumour markers • • • • • AFP levels are elevated 50%-70% NSGCT hCG levels are elevated in 40%-60% NSGCT. AFP has a half-life of 5-7 days hCG has a half-life of 36 hours. Important to follow response after orchiectomy • LDH is non-specific measure of tumor burden Risk stratification • • • • • • Good-risk nonseminoma Testicular or retroperitoneal primary tumor, and No nonpulmonary visceral metastases, and Good markers; all of:Alpha-fetoprotein (AFP) < 1,000 ng/mL, and Human chorionic gonadotropin (hCG) < 5,000 IU/mL (1,000 ng/mL), and Lactate dehydrogenase (LDH) < 1.5 times the upper limit of normal • • • • • • Intermediate-risk nonseminoma Testicular or retroperitoneal primary tumor, and No nonpulmonary visceral metastases, and Intermediate markers; any of:AFP 1,000 to 10,000 ng/mL, or hCG 5,000 IU/L to 50,000 IU/L, or LDH 1.5 to 10 times the upper limit of normal • • • • • • Poor-risk nonseminoma Mediastinal primary, or Nonpulmonary visceral metastases, or Poor markers; any of:AFP > 10,000 ng/mL, or hCG > 50,000 IU/mL (10,000 ng/mL), or LDH > 10 times the upper limit of normal Risk stratification • • • • • • • • • • Good-risk seminoma Any primary site, and No nonpulmonary visceral metastases, and Normal AFP, any hCG, any LDH Intermediate-risk seminoma Any primary site, and Nonpulmonary visceral metastases, and Normal AFP, any hCG, any LDH Poor-risk seminoma No such thing!! Treatment Post Orchidectomy… Seminoma Stage IA and B: radiation therapy vs surveillance (? Chemo) NSGCT Stage IA retroperitoneal lymph node dissection vs surveillance Stage IB retroperitoneal lymph node dissection vs surveillance vs chemotherapy Higher stages-chemo, f/b surgery as needed Retroperitoneal Lymph Node Dissection Why? • Non-seminomas are more aggressive than seminomas • RPLND is used to guide chemotherapy – No of +ive nodes correlates to cycles of chemo Surveillance NCCN guidelines • CT q 2-3 months for first year or two • Then q4, q6 • Labs, CXR q month for year one, then q 2 months, etc • Issues are compliance, anxiety Question 1 The most common presenting complaint for a testicular cancer is: a) a painless swelling of a single teste b) a red, painful scrotum c) haematuria d) back pain Question 2 • All of the following are a risk factor for testicular cancers, save a) Cryptorchidism b) Maternal DES exposure c) Caucasian race d) Repeated testicular trauma Question 3 The following statements are false, save a) Testicular cancer is the most common cancer of infancy b) There are more men aged 15-25 diagnosed with testicular cancer than >50 c) Unilateral surgical orchidectomy precludes the chance of testicular cancer recurring d) Unilateral surgical orchidectomy is the gold standard diagnostic procedure for testicular cancer Question 4 Routine workup and staging of diagnosed testicular cancer should include: a) a-FP b) B-HcG c) CT A/P + C d) PET scan Question 5 The following are incorrect about Seminomas, save a) Ultrasound features often involve heterogenous cystic components b) aFP is often raised and used for prognostication c) Para-aortic radiotherapy is often indicated d) Patients with metastatic disease have a poor prognosiss